Digital Twins in Oncology: From Multimodal Data Integration to Precision Clinical Practice.
- 1Madha Medical College and Research InstituteThandalamTamil NaduIndia.
- 2Department of Medical Sciences and TechnologyIndian Institute of Technology (IIT) MadrasChennaiTamil NaduIndia.
- 3Apollo Cancer Centre, Voluntary Health ServiceChennaiTamil NaduIndia.
Abstract
Oncology digital twins are patient-specific computational models that are built by combining electronic health records, multiomics genomic data, and diagnostic imaging to simulate individual tumor biology and predict multiple treatment-related outcomes. Conceptually originated from aerospace engineering, it has matured clinically through convergent advances in radiomics, mechanistic tumor modeling, pharmacokinetic- pharmacodynamic systems, federated machine learning, and, most recently, large language model (LLM)-based clinical interfaces and agentic artificial intelligence (AI). For a practicing radiologist, digital twins offer a transformative role: imaging-derived quantitative features serve as the primary data, positioning diagnostic imaging at the center of these personalized oncology workflows. Key clinical applications especially in oncology span from chemotherapy response prediction, immunotherapy patient selection, personalized radiation planning, tumor progression modeling, and treatment toxicity forecasting. Several of these applications are achievable with current technology without any significant infrastructure investment. Substantial challenges include imaging data standards, absence of prospective validation, algorithmic bias in underrepresented populations, and regulatory uncertainty for continuously self-updating AI. This narrative review provides radiologists with a balanced, comprehensive overview of digital twin architecture, advanced enabling technologies, current clinical evidence, a practical roadmap for implementation, and a candid appraisal of barriers to adoption.
Related
- Clinical Translation of Artificial Intelligence in Oncology: Real-World Validation, Workflow Integration, and Precision Medicine Applications
- Precision immuno-oncology in triple-negative breast cancer: from PD-L1 to multimodal biomarkers, ADC–ICI combinations, and global real-world integration
- From discordance to clinical decision support: integrating longitudinal imaging and ctDNA through multimodal artificial intelligence in precision oncology
- EXPLAINABLE AI-DRIVEN CLINICAL DECISION SUPPORT SYSTEMS IN PRECISION ONCOLOGY: INTERPRETABLE MODELS FOR MULTIMODAL CANCER CARE
- Radiomics-driven multimodal integration in precision radiotherapy for nasopharyngeal carcinoma— current evidence, clinical barriers, and future directions
BibTeX
@article{vairavan2026digital,
title = {{Digital Twins in Oncology: From Multimodal Data Integration to Precision Clinical Practice.}},
author = {Annamalai Vairavan and Rupsa Bhattacharjee and Bagyam Raghavan},
journal = {The Indian journal of radiology \& imaging},
year = {2026},
month = sep,
doi = {10.1055/s-0046-1827804},
url = {https://europepmc.org/article/MED/42921620},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Digital Twins in Oncology: From Multimodal Data Integration to Precision Clinical Practice.
AU - Annamalai Vairavan
AU - Rupsa Bhattacharjee
AU - Bagyam Raghavan
PY - 2026
DA - 2026/09/03
JO - The Indian journal of radiology & imaging
DO - 10.1055/s-0046-1827804
UR - https://europepmc.org/article/MED/42921620
AB - Oncology digital twins are patient-specific computational models that are built by combining electronic health records, multiomics genomic data, and diagnostic imaging to simulate individual tumor biology and predict multiple treatment-related outcomes. Conceptually originated from aerospace engineering, it has matured clinically through convergent advances in radiomics, mechanistic tumor modeling, pharmacokinetic- pharmacodynamic systems, federated machine learning, and, most recently, large language model (LLM)-based clinical interfaces and agentic artificial intelligence (AI). For a practicing radiologist, digital twins offer a transformative role: imaging-derived quantitative features serve as the primary data, positioning diagnostic imaging at the center of these personalized oncology workflows. Key clinical applications especially in oncology span from chemotherapy response prediction, immunotherapy patient selection, personalized radiation planning, tumor progression modeling, and treatment toxicity forecasting. Several of these applications are achievable with current technology without any significant infrastructure investment. Substantial challenges include imaging data standards, absence of prospective validation, algorithmic bias in underrepresented populations, and regulatory uncertainty for continuously self-updating AI. This narrative review provides radiologists with a balanced, comprehensive overview of digital twin architecture, advanced enabling technologies, current clinical evidence, a practical roadmap for implementation, and a candid appraisal of barriers to adoption.
SN - 0971-3026
SN - 1998-3808
ER -